REPORT ID 6271

EMEA (Europe, Middle East and Africa) Subunit Vaccine Market Report 2017

Publish Date
25-Dec-17
Pages
101
Format
Electronic (PDF)

In this report, the EMEA Subunit Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Subunit Vaccine for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Subunit Vaccine market competition by top manufacturers/players, with Subunit Vaccine sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    GE Healthcare Life Sciences
    GSK
    Reber Genetics
    Merck
    Sanofi
    Virbac
    Shenzhen Kangtai Biological Products
    ...

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Live Attenuated Vaccine
    Inactivated Vaccine

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Clinics
    Public Services
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Subunit Vaccine Market Report 2017
1 Subunit Vaccine Overview
    1.1 Product Overview and Scope of Subunit Vaccine
    1.2 Classification of Subunit Vaccine
        1.2.1 EMEA Subunit Vaccine Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Subunit Vaccine Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Live Attenuated Vaccine
        1.2.4 Inactivated Vaccine
    1.3 EMEA Subunit Vaccine Market by Application/End Users
        1.3.1 EMEA Subunit Vaccine Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Hospital
        1.3.3 Clinics
        1.3.4 Public Services
        1.3.5 Others
    1.4 EMEA Subunit Vaccine Market by Region
        1.4.1 EMEA Subunit Vaccine Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Subunit Vaccine (2012-2022)
        1.5.1 EMEA Subunit Vaccine Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Subunit Vaccine Revenue and Growth Rate (2012-2022)

2 EMEA Subunit Vaccine Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Subunit Vaccine Market Competition by Players/Manufacturers
        2.1.1 EMEA Subunit Vaccine Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Subunit Vaccine Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Subunit Vaccine Sale Price by Players (2012-2017)
    2.2 EMEA Subunit Vaccine (Volume and Value) by Type/Product Category
        2.2.1 EMEA Subunit Vaccine Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Subunit Vaccine Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Subunit Vaccine Sale Price by Type (2012-2017)
    2.3 EMEA Subunit Vaccine (Volume) by Application
    2.4 EMEA Subunit Vaccine (Volume and Value) by Region
        2.4.1 EMEA Subunit Vaccine Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Subunit Vaccine Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Subunit Vaccine Sales Price by Region (2012-2017)

3 Europe Subunit Vaccine (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Subunit Vaccine Sales and Value (2012-2017)
        3.1.1 Europe Subunit Vaccine Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Subunit Vaccine Revenue and Growth Rate (2012-2017)
    3.2 Europe Subunit Vaccine Sales and Market Share by Type
    3.3 Europe Subunit Vaccine Sales and Market Share by Application
    3.4 Europe Subunit Vaccine Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Subunit Vaccine Sales Volume by Countries (2012-2017)
        3.4.2 Europe Subunit Vaccine Revenue by Countries (2012-2017)
        3.4.3 Germany Subunit Vaccine Sales and Growth Rate (2012-2017)
        3.4.4 France Subunit Vaccine Sales and Growth Rate (2012-2017)
        3.4.5 UK Subunit Vaccine Sales and Growth Rate (2012-2017)
        3.4.6 Russia Subunit Vaccine Sales and Growth Rate (2012-2017)
        3.4.7 Italy Subunit Vaccine Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Subunit Vaccine Sales and Growth Rate (2012-2017)

4 Middle East Subunit Vaccine (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Subunit Vaccine Sales and Value (2012-2017)
        4.1.1 Middle East Subunit Vaccine Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Subunit Vaccine Revenue and Growth Rate (2012-2017)
    4.2 Middle East Subunit Vaccine Sales and Market Share by Type
    4.3 Middle East Subunit Vaccine Sales and Market Share by Application
    4.4 Middle East Subunit Vaccine Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Subunit Vaccine Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Subunit Vaccine Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Subunit Vaccine Sales and Growth Rate (2012-2017)
        4.4.4 Israel Subunit Vaccine Sales and Growth Rate (2012-2017)
        4.4.5 UAE Subunit Vaccine Sales and Growth Rate (2012-2017)
        4.4.6 Iran Subunit Vaccine Sales and Growth Rate (2012-2017)

5 Africa Subunit Vaccine (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Subunit Vaccine Sales and Value (2012-2017)
        5.1.1 Africa Subunit Vaccine Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Subunit Vaccine Revenue and Growth Rate (2012-2017)
    5.2 Africa Subunit Vaccine Sales and Market Share by Type
    5.3 Africa Subunit Vaccine Sales and Market Share by Application
    5.4 Africa Subunit Vaccine Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Subunit Vaccine Sales Volume by Countries (2012-2017)
        5.4.2 Africa Subunit Vaccine Revenue by Countries (2012-2017)
        5.4.3 South Africa Subunit Vaccine Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Subunit Vaccine Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Subunit Vaccine Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Subunit Vaccine Sales and Growth Rate (2012-2017)

6 EMEA Subunit Vaccine Manufacturers/Players Profiles and Sales Data
    6.1 GE Healthcare Life Sciences
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Subunit Vaccine Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 GE Healthcare Life Sciences Subunit Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 GSK
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Subunit Vaccine Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 GSK Subunit Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Reber Genetics
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Subunit Vaccine Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Reber Genetics Subunit Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Merck
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Subunit Vaccine Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Merck Subunit Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Sanofi
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Subunit Vaccine Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Sanofi Subunit Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Virbac
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Subunit Vaccine Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Virbac Subunit Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Shenzhen Kangtai Biological Products
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Subunit Vaccine Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Shenzhen Kangtai Biological Products Subunit Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    ...

7 Subunit Vaccine Manufacturing Cost Analysis
    7.1 Subunit Vaccine Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Subunit Vaccine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Subunit Vaccine Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Subunit Vaccine Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Subunit Vaccine Market Forecast (2017-2022)
    11.1 EMEA Subunit Vaccine Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Subunit Vaccine Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Subunit Vaccine Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Subunit Vaccine Price and Trend Forecast (2017-2022)
    11.2 EMEA Subunit Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Subunit Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Subunit Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Subunit Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Subunit Vaccine Sales Forecast by Type (2017-2022)
    11.7 EMEA Subunit Vaccine Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer